Anti-hepatocyte specific antigen, also known as anti-Hep-Par1, recognizes both benign and malignant liver-derived tissues including such tumors as hepatoblastoma, hepatocellular carcinoma, and hepatic adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating hepatocellular carcinomas with adenoid features from adenocarcinomas, either primary in the liver or metastatic lesions to the liver.1-3 In labeling hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.4,5
1. Asa SL, et al. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med. 1982; 106:360-3.
2. Duello TM, et al. Immunocytochemistry of prolactin-producing human pituitary adenomas. Am J Anat. 1980; 158:463-9.
3. Minniti G, et al. Giant prolactinomas presenting as skull base tumors. Surg Neurol. 2002; 57:99-103.
4. Popadic A, et al. Malignant prolactinoma: case report and review of the literature. Surg Neurol. 1999; 51:47-54.
5. Nevalainen MT, et al. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest. 1997; 99:618-2.
Literature:
Manufacturer site:
Prolactin (EP193)
Rabbit Monoclonal
Anti-hepatocyte specific antigen, also known as anti-Hep-Par1, recognizes both benign and malignant liver-derived tissues including such tumors as hepatoblastoma, hepatocellular carcinoma, and hepatic adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating hepatocellular carcinomas with adenoid features from adenocarcinomas, either primary in the liver or metastatic lesions to the liver.1-3 In labeling hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.4,5
1. Asa SL, et al. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med. 1982; 106:360-3.
2. Duello TM, et al. Immunocytochemistry of prolactin-producing human pituitary adenomas. Am J Anat. 1980; 158:463-9.
3. Minniti G, et al. Giant prolactinomas presenting as skull base tumors. Surg Neurol. 2002; 57:99-103.
4. Popadic A, et al. Malignant prolactinoma: case report and review of the literature. Surg Neurol. 1999; 51:47-54.
5. Nevalainen MT, et al. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest. 1997; 99:618-2.
Rabbit Monoclonal
Anti-hepatocyte specific antigen, also known as anti-Hep-Par1, recognizes both benign and malignant liver-derived tissues including such tumors as hepatoblastoma, hepatocellular carcinoma, and hepatic adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating hepatocellular carcinomas with adenoid features from adenocarcinomas, either primary in the liver or metastatic lesions to the liver.1-3 In labeling hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.4,5
1. Asa SL, et al. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med. 1982; 106:360-3.
2. Duello TM, et al. Immunocytochemistry of prolactin-producing human pituitary adenomas. Am J Anat. 1980; 158:463-9.
3. Minniti G, et al. Giant prolactinomas presenting as skull base tumors. Surg Neurol. 2002; 57:99-103.
4. Popadic A, et al. Malignant prolactinoma: case report and review of the literature. Surg Neurol. 1999; 51:47-54.
5. Nevalainen MT, et al. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest. 1997; 99:618-2.
